|
[1] CHACKO KR,REINUS J. Spectrum of alcoholic liver disease[J]. Clin Liver Dis,2016,20(3):419-427.
|
|
[2] WHO. Global status report on alcohol and health 2018[EB/OL].[2018-9-21]. https://www. who. int/substance_abuse/publications/global_alcohol_report/en/．
|
|
[3] SEITZ HK,BATALLER R,CORTEZ-PINTO H,et al. Alcoholic liver disease[J]. Nat Rev Dis Primers,2018,4(1):16.
|
|
[4] YANG FN,HUANG J. Research progress in genetic susceptibility to alcoholic liver disease[J]. J Clin Hepatol,2017,33(2):379-383.(in Chinese)杨馥宁，黄晶．酒精性肝病的遗传易感性研究现状[J]．临床肝胆病杂志，2017,33(2):379-383.
|
|
[5] GAO B,ZAKHARI S. Zakim and Boyer’s hepatology[M].Philadelphia,PA:Elsevier,2018:334-344.
|
|
[6] European Association for the Study of the Liver. EASL clinical practice guidelines:Management of alcohol-related liver disease[J]. J Hepatol,2018,69(1):154-181.
|
|
[7] LI S,TAN HY,WANG N,et al. The role of oxidative stress and antioxidants in liver diseases[J]. Int J Mol Sci,2015,16(11):26087-26124.
|
|
[8] LOUVET A,MATHURIN P. Alcoholic liver disease:Mechanisms of injury and targeted treatment[J]. Nat Rev Gastroenterol Hepatol,2015,12(4):231-242.
|
|
[9] CENI E,MELLO T,GALLI A. Pathogenesis of alcoholic liver disease:Role of oxidative metabolism[J]. World J Gastroenterol,2014,20(47):17756-17772.
|
|
[10] CEDERBAUM AI. Molecular mechanisms of the microsomal mixed function oxidases and biological and pathological implications[J]. Redox Biol,2015,4:60-73.
|
|
[11] MUELLER S,PECCERELLA T,QIN H,et al. Carcinogenic etheno DNA adducts in alcoholic liver disease:Correlation with cytochrome P-4502E1 and fibrosis[J]. Alcohol Clin Exp Res,2018,42(2):252-259.
|
|
[12] CHEN D,LIN XX,CHEN Y. Research on the progress of alcoholic liver disease pathogenesis related to CYP2E1[J]. Chin J Clin Pharmacol Ther,2017,22(2):198-203.(in Chinese)陈丹，林秀贤，陈尧．CYP2E1调控酒精性肝病发病机制的研究进展[J]．中国临床药理学与治疗学，2017,22(2):198-203.
|
|
[13] LU Y,CEDERBAUM AI. Cytochrome P450s and alcoholic liver disease[J]. Curr Pharm Des,2018,24(14):1502-1517.
|
|
[14] ZHAO N,GUO FF,XIE KQ,et al. Targeting Nrf-2 is a promising intervention approach for the prevention of ethanol-induced liver disease[J]. Cell Mol Life Sci,2018,75(17):3143-3157.
|
|
[15] SUN J,FU J,LI L,et al. Nrf2 in alcoholic liver disease[J].Toxicol Appl Pharmacol,2018,357:62-69.
|
|
[16] TANG W,JIANG YF,PONNUSAMY M,et al. Role of Nrf2 in chronic liver disease[J]. World J Gastroenterol,2014,20(36):13079-13087.
|
|
[17] XIE Y,ZHOU X,CHEN L,et al. Cloning and characterization of a novel sigma-like glutathione S-transferase from the giant panda parasitic nematode,Baylisascaris schroederi[J].Parasit Vectors,2015,8:44.
|
|
[18] HOLLMAN AL,TCHOUNWOU PB,HUANG HC. The association between gene-environment interactions and diseases involving the human GST superfamily with SNP variants[J]. Int J Environ Res Public Health,2016,13(4):379.
|
|
[19] RUZZA P,CALDERAN A. Glutathione Transferase(GST)-activated prodrugs[J]. Pharmaceutics,2013,5(2):220-231.
|
|
[20] BALTRUSKEVICIENE E,KAZBARIENE B,BADARAS R,et al.Glutathione and glutathione S-transferase levels in patients with liver metastases of colorectal cancer and other hepatic disorders[J]. Turk J Gastroenterol,2016,27(4):336-341.
|
|
[21] MARI M,CEDERBAUM AI. Induction of catalase,alpha,and microsomal glutathione S-transferase in CYP2E1 overexpressing HepG2 cells and protection against short-term oxidative stress[J]. Hepatology,2001,33(3):652-661.
|
|
[22] CHANG YC,LIU FP,MA X,et al. Glutathione S-transferase A1-a sensitive marker of alcoholic injury on primary hepatocytes[J]. Hum Exp Toxicol,2017,36(4):386-394.
|
|
[23] BROEKMAN MM,BOS C,TE MORSCHE RH,et al. GST Theta null genotype is associated with an increased risk for ulcerative colitis:A case-control study and meta-analysis of GST Mu and GST Theta polymorphisms in inflammatory bowel disease[J]. J Hum Genet,2014,59(10):575-580.
|
|
[24] MARCOS M,PASTOR I,CHAMORRO AJ,et al. Meta-analysis:Glutathione-S-transferase allelic variants are associated with alcoholic liver disease[J]. Aliment Pharmacol Ther,2011,34(10):1159-1172.
|
|
[25] MANSOORI AA,JAIN SK. ADH1B,ALDH2,GSTM1 and GSTT1gene polymorphic frequencies among alcoholics and controls in the arcadian population of Central India[J]. Asian Pac J Cancer Prev,2018,19(3):725-731.
|
|
[26] BHATTACHARJEE P,PAUL S,BANERJEE M,et al. Functional compensation of glutathione S-transferase M1(GSTM1)null by another GST superfamily member,GSTM2[J]. Sci Rep,2013,3:2704.
|
|
[27] SCHNEKENBURGER M,KARIUS T,DIEDERICH M. Regulation of epigenetic traits of the glutathione S-transferase P1gene:From detoxification toward cancer prevention and diagnosis[J]. Front Pharmacol,2014,5:170.
|
|
[28] KALYANARAMAN B. Teaching the basics of redox biology to medical and graduate students:Oxidants,antioxidants and disease mechanisms[J]. Redox Biol,2013,1(1):244-257.
|
|
[29] WANG Y,BRANICKY R,NO¨EA,et al. Superoxide dismutases:Dual roles in controlling ROS damage and regulating ROS signaling[J]. J Cell Biol,2018,217(6):1915-1928.
|
|
[30] LEWANDOWSKI，KEPINSKA M,MILNEROWICZ H. Inhibition of copper-zinc superoxide dismutase activity by selected environmental xenobiotics[J]. Environ Toxicol Pharmacol,2018,58:105-113.
|
|
[31] HUANG YS,WANG LY,CHANG CH,et al. Superoxide dismutase 2 genetic variation as a susceptibility risk factor for alcoholic cirrhosis[J]. Alcohol Alcohol,2016,51(6):633-637.
|
|
[32] CHENG ML,LU YF,CHEN H,et al. Liver expression of Nrf2-related genes in different liver diseases[J]. Hepatobiliary Pancreat Dis Int,2015,14(5):485-491.
|
|
[33] SIEGEL D,GUSTAFSON DL,DEHN DL,et al. NAD(P)H:Quinone oxidoreductase 1:Role as a superoxide scavenger[J]. Mol Pharmacol,2004,65(5):1238-1247.
|
|
[34] VIJAYAN V,WAGENER F,IMMENSCHUH S. The macrophage heme-heme oxygenase-1 system and its role in inflammation[J]. Biochem Pharmacol,2018,153:159-167.
|
|
[35] LIU S,TIAN L,CHAI G,et al. Targeting heme oxygenase-1by quercetin ameliorates alcohol-induced acute liver injury via inhibiting NLRP3 inflammasome activation[J]. Food Funct,2018,9(8):4184-4193.
|
|
[36] HAN KH,HASHIMOTO N,FUKUSHIMA M. Relationships among alcoholic liver disease,antioxidants,and antioxidant enzymes[J]. World J Gastroenterol,2016,22(1):37-49.
|
|
[37] GRASSELLI E,COMPALATI AD,VOCI A,et al. Altered oxidative stress/antioxidant status in blood of alcoholic subjects is associated with alcoholic liver disease[J]. Drug Alcohol Depend,2014,143:112-119.
|
|
[38] ZHANG H,XUE L,LI B,et al. Vitamin D protects against alcohol-induced liver cell injury within an NRF2-ALDH2 feedback loop[J]. Mol Nutr Food Res,2019,63(6):e1801014.
|
|
[39] ZHONG ZL,ZHANG F,JIANG YH,et al. Protective effect of ferulic acid on acute liver injury[J]. Chin J Clin Pharmacol Ther,2018,23(12):1335-1339.(in Chinese)钟正灵，张飞，江玉华，等．阿魏酸对急性肝损伤的保护作用[J]．中国临床药理学与治疗学，2018,23(12):1335-1339.
|
DownLoad: